Pillstats
Rx only · Tablet · Oral

Candesartan

Candesartan Cilexetil

3 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US7 NDCs
3 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATCC09CA06
RxCUI (US)214354
US makers3 labelers
Packages20
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 10 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.161$0.321$0.482$0.642Dec 2025Apr 2026Jul 2026
$0.519
Latest avg · Jul 22, 2026
-7%
Since Dec 17, 2025
3
Active US suppliers
90%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

1.3K2.7K4.0K5.3K2025 Q12025 Q22025 Q32025 Q42026 Q1
4.6K
Rx · 2026 Q1
229K
Units dispensed
+42%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it3 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Macleods Pharmaceuticals Limitedunknown16SUPPLYING
Bryant Ranch Prepackrepackager2SUPPLYING
NorthStar RxLLCunknown2SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Mar 22, 2021
    RECALLRecall (Class III): Candesartan Cilexetil Tablets, USP, 4 mg, 30-count bottles, Rx only, Manufactured for: Macleods Pharma USA, Inc., Plain…

    Failed Impurities/Degradation Specifications — Recalling firm: Macleods Pharma Usa Inc — Nationwide within the United States